These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15914125)

  • 21. Rapamycin effects transcriptional programs in smooth muscle cells controlling proliferative and inflammatory properties.
    Zohlnhöfer D; Nührenberg TG; Neumann FJ; Richter T; May AE; Schmidt R; Denker K; Clauss MA; Schömig A; Baeuerle PA
    Mol Pharmacol; 2004 Apr; 65(4):880-9. PubMed ID: 15044617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells.
    Matter CM; Rozenberg I; Jaschko A; Greutert H; Kurz DJ; Wnendt S; Kuttler B; Joch H; Grünenfelder J; Zünd G; Tanner FC; Lüscher TF
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):286-92. PubMed ID: 17204907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phorbol 12-myristate 13-acetate and serum synergize to promote rapamycin-insensitive cell proliferation via protein kinase C-eta.
    Martin PM; Aeder SE; Chrestensen CA; Sturgill TW; Hussaini IM
    Oncogene; 2007 Jan; 26(3):407-14. PubMed ID: 16832347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emodin induces growth arrest and death of human vascular smooth muscle cells through reactive oxygen species and p53.
    Wang X; Zou Y; Sun A; Xu D; Niu Y; Wang S; Wang K; Ge J
    J Cardiovasc Pharmacol; 2007 May; 49(5):253-60. PubMed ID: 17513942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human vascular smooth muscle cells from restenosis or in-stent stenosis sites demonstrate enhanced responses to p53: implications for brachytherapy and drug treatment for restenosis.
    Scott S; O'Sullivan M; Hafizi S; Shapiro LM; Bennett MR
    Circ Res; 2002 Mar; 90(4):398-404. PubMed ID: 11884368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation.
    Li B; Yang L; Shen J; Wang C; Jiang Z
    Anesth Analg; 2007 Oct; 105(4):1034-41, table of contents. PubMed ID: 17898384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sirolimus inhibits platelet-derived growth factor-induced collagen synthesis in rat vascular smooth muscle cells.
    Park J; Ha H; Ahn HJ; Kang SW; Kim YS; Seo JY; Kim MS
    Transplant Proc; 2005 Oct; 37(8):3459-62. PubMed ID: 16298629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation.
    Wu YJ; Bond M; Sala-Newby GB; Newby AC
    Circ Res; 2006 May; 98(9):1141-50. PubMed ID: 16574903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiproliferative action of cudraflavone B, isolated from Cudrania tricuspidata, through the downregulation of pRb phosphorylation in aortic smooth muscle cell proliferation signaling.
    Kim TJ; Han HJ; Lim Y; Song MC; Kim J; Hong JT; Yoo HS; Pyo MY; Hwang BY; Lee MK; Yun YP
    J Cardiovasc Pharmacol; 2009 Apr; 53(4):341-8. PubMed ID: 19295442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNA interference targeting ORC1 gene suppresses the proliferation of vascular smooth muscle cells in rats.
    Shu MQ; Qin YL; Jiang MH
    Exp Mol Pathol; 2008 Jun; 84(3):206-12. PubMed ID: 18499104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck.
    Amornphimoltham P; Patel V; Sodhi A; Nikitakis NG; Sauk JJ; Sausville EA; Molinolo AA; Gutkind JS
    Cancer Res; 2005 Nov; 65(21):9953-61. PubMed ID: 16267020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
    Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
    Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In human endothelial cells amino acids inhibit insulin-induced Akt and ERK1/2 phosphorylation by an mTOR-dependent mechanism.
    Pellegatta F; Catapano AL; Luzi L; Terruzzi I
    J Cardiovasc Pharmacol; 2006 May; 47(5):643-9. PubMed ID: 16775502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
    Zhao FH; Chen YD; Jin ZN; Lu SZ
    Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the mammalian target of rapamycin pathway and the effect of rapamycin on target expression and cellular proliferation in osteosarcoma cells from dogs.
    Gordon IK; Ye F; Kent MS
    Am J Vet Res; 2008 Aug; 69(8):1079-84. PubMed ID: 18672974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug delivery.
    Wessely R; Blaich B; Belaiba RS; Merl S; Görlach A; Kastrati A; Schömig A
    Thromb Haemost; 2007 Jun; 97(6):1003-12. PubMed ID: 17549304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells.
    Liang KW; Yin SC; Ting CT; Lin SJ; Hsueh CM; Chen CY; Hsu SL
    Eur J Pharmacol; 2008 Aug; 590(1-3):343-54. PubMed ID: 18590725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular mechanism through which parathyroid hormone-related protein induces proliferation in arterial smooth muscle cells: definition of an arterial smooth muscle PTHrP/p27kip1 pathway.
    Fiaschi-Taesch N; Sicari BM; Ubriani K; Bigatel T; Takane KK; Cozar-Castellano I; Bisello A; Law B; Stewart AF
    Circ Res; 2006 Oct; 99(9):933-42. PubMed ID: 17023675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of dehydrozingerone on vascular smooth muscle cell function.
    Liu Y; Dolence J; Ren J; Rao M; Sreejayan N
    J Cardiovasc Pharmacol; 2008 Nov; 52(5):422-9. PubMed ID: 19033821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of RNA interference targeting mammalian target of rapamycin on the proliferation of vascular smooth muscle cell and the intimal hyperplasia].
    Hu XH; Zhang Q; Yang J; Liu CW; Zhang ZS; Yang DH
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):58-62. PubMed ID: 17403315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.